UniQuest is one of Australia’s leading research commercialisation companies, specialising in global technology transfer and facilitating access for all business sectors to world class university expertise, intellectual property and facilities.

UniQuest's innovation portfolio includes Australia's first blockbuster vaccine Gardasil®, Australia's largest biotech IPO QRxPharma Ltd, the internationally acclaimed Triple P Positive Parenting Program, and UQ’s superconductor technology used in two-thirds of the world's MRI machines.